Cargando…

Pancreas Cancer Survival in the Gemcitabine Era

After multiple positive studies, gemcitabine, approved for the treatment of pancreas cancer by the FDA in 1977, became standard of care. Whether this therapeutic advance has translated into longer survival for pancreas cancer patients in general has not been established. This study, derived from SEE...

Descripción completa

Detalles Bibliográficos
Autores principales: Wachtel, Mitchell S., Xu, K. Tom, Zhang, Yan, Chiriva-Internati, Maurizio, Frezza, Eldo E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161658/
https://www.ncbi.nlm.nih.gov/pubmed/21892307